Maria E Taskinen — ASN Events
  1. Schedule
  2. Maria E Taskinen

Maria Taskinen

The Institute of Cancer Research, London, GREATER LONDON, United Kingdom

  • This delegate is presenting an abstract at this event.
Presentations this author is a contributor to:

Clinical candidate drug NXP800 inhibits HSF1 pathway and activates the Integrated Stress Response (ISR) via GCN2 in ARID1A mutant ovarian cancer (#259)

5:35 PM
Maria E Taskinen
Poster Session 2